IVIG (Gamunex-C) Treatment Study for POTS Subjects (iSTAND)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT03919773

Recruitment Status : Enrolling by invitation

First Posted : April 18, 2019

Last Update Posted : January 24, 2022

Sponsor:

Collaborators:

Grifols Biologicals, LLC

Dysautonomia International

Information provided by (Responsible Party):

Steven Vernino, University of Texas Southwestern Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Enrolling by invitation
Estimated Primary Completion Date :	September 2023
Estimated Study Completion Date :	December 2023

Publications:

Goodman BP, Crepeau A, Dhawan PS, Khoury JA, Harris LA. Spectrum of Autonomic Nervous System Impairment in Sjögren Syndrome. Neurologist. 2017 Jul;22(4):127-130. doi: 10.1097/NRL.0000000000000134.

To Top